24/7 Market News Snapshot 05 February, 2025 – Accuray Incorporated (NASDAQ:ARAY)

DENVER, Colo., 05 February, 2025 (247marketnews.com) – (NASDAQ:ARAY) are discussed in this article.
Accuray Incorporated has displayed notable market strength, with its stock opening at $2.32 and recently trading at $2.431, reflecting a 4.33% increase. A trading volume of 1.59 million shares indicates strong investor interest, suggesting a positive market sentiment and potential for further growth. Technical analysis reveals that Accuray is likely breaking through key resistance levels, which could lead to additional gains. Traders are advised to keep an eye on support levels near the opening price and ongoing volume trends to confirm bullish momentum.

In conjunction with this market performance, Accuray has reported robust financial results for the second quarter of fiscal year 2025, which ended on December 31, 2024. The company achieved total net revenue of $116.2 million, an increase of 8% year-over-year. This growth is significantly attributed to a 19% rise in product revenue, totaling $61.2 million, showcasing sustained demand for Accuray’s innovative radiotherapy solutions.

Moreover, Accuray posted a net income of $2.5 million for the quarter, a remarkable turnaround from a net loss of $9.6 million in the same quarter last year. The company also improved its adjusted EBITDA to $9.6 million, highlighting enhanced operational efficiency, while successfully lowering operating expenses by 7%.

CEO Suzanne Winter emphasized the positive trends observed in emerging markets and increasing customer demand, particularly for the Tomo C System and the newly launched Helix system. The company has raised its fiscal year 2025 guidance, anticipating revenues between $463 million and $475 million and adjusted EBITDA of $28.5 million to $31.0 million. These projections indicate a steady recovery in the market and reflect Accuray’s commitment to improving patient care through innovative radiation therapy solutions.

Related news for (ARAY)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.